You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CIMETIDINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cimetidine Hydrochloride patents expire, and when can generic versions of Cimetidine Hydrochloride launch?

Cimetidine Hydrochloride is a drug marketed by Cosette, Endo Operations, Hospira, Luitpold, Teva Parenteral, Ani Pharms, Chartwell Molecular, Cycle, G And W Labs Inc, Pai Holdings Pharm, Pharm Assoc, and Pharmobedient Cnsltg. and is included in twenty-one NDAs.

The generic ingredient in CIMETIDINE HYDROCHLORIDE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cimetidine Hydrochloride

A generic version of CIMETIDINE HYDROCHLORIDE was approved as cimetidine hydrochloride by PAI HOLDINGS PHARM on October 28th, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CIMETIDINE HYDROCHLORIDE?
  • What are the global sales for CIMETIDINE HYDROCHLORIDE?
  • What is Average Wholesale Price for CIMETIDINE HYDROCHLORIDE?
Drug patent expirations by year for CIMETIDINE HYDROCHLORIDE
Recent Clinical Trials for CIMETIDINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 4
University of WashingtonPhase 4
Wollo UniversityPhase 4

See all CIMETIDINE HYDROCHLORIDE clinical trials

Pharmacology for CIMETIDINE HYDROCHLORIDE

US Patents and Regulatory Information for CIMETIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074296-001 Mar 28, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharm Assoc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 075560-001 Mar 15, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 074468-004 Dec 29, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074422-001 Jan 31, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074344-001 Jan 31, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 075110-001 Jun 18, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cimetidine hydrochloride INJECTABLE;INJECTION 074269-001 Dec 27, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.